Cytoprotection Concepts for Ischemic Stroke in the Recanalization Era
Johannes Boltze1, Marc Fisher2
1University of Warwick, School of Life Sciences, Coventry, UK.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|February 19, 2026
Summary
Cytoprotective therapies, once unsuccessful, are now being re-evaluated to enhance outcomes for ischemic stroke patients undergoing recanalization treatments like endovascular thrombectomy. Refined strategies are crucial for future clinical success.
Area of Science:
- Neurology
- Translational Medicine
- Pharmacology
Background:
- Recanalization therapies, particularly endovascular thrombectomy, have transformed acute ischemic stroke management.
- Previous cytoprotective strategies failed in the pre-recanalization era but are now being revisited.
- The integration of cytoprotective agents with recanalization therapies necessitates optimized application strategies.
Purpose of the Study:
- To review current cytoprotection concepts and their pathophysiological rationale in ischemic stroke.
- To provide an overview of cytoprotective approaches in clinical trials.
- To discuss advancements in preclinical and clinical research for cytoprotective therapies.
Main Methods:
- Literature review of cytoprotection concepts, pathophysiology, and clinical trials.
- Analysis of preclinical testing models and their relevance to human stroke.
- Discussion of brain imaging, biomarkers, and clinical trial design.
Main Results:
- Cytoprotective therapies show renewed promise when combined with recanalization treatments.
- Refined application strategies are essential for successful clinical translation.
- Improved preclinical models and advanced imaging are key for future research.
Conclusions:
- Cytoprotection represents a significant area of research to augment recanalization therapies for ischemic stroke.
- Optimizing preclinical models, patient selection via biomarkers, and innovative clinical trial designs are critical for advancing cytoprotective treatments.
- Future research should focus on integrating these elements for improved stroke patient outcomes.
Related Concept Videos
01:15Ischemic Stroke l: Introduction
53
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
53
01:15Ischemic Stroke ll: Pathophysiology
68
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
68
01:26Transient Ischemic Attack l: Introduction
34
A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
34